Skip to content

PTSD comorbidity

TL;DR — Depression, substance-use disorders, chronic pain, sleep disorders and TBI commonly co-occur with PTSD, but co-occurrence does not make them symptoms of PTSD. A component network meta-analysis specifically examined PTSD with comorbid mental-health problems after complex events and found that commonly available interventions can help, while heterogeneity limits component conclusions (Coventry 2020, PMID 32813696). Chronic-pain/CPTSD review found only 13 eligible studies and just four explicitly testing trauma factors against pain outcomes (Karimov-Zwienenberg 2024, PMID 39213321). Depression and GAD are cross-linked as neighbouring conditions; pooled anxiety or depression effects are never relabelled as PTSD effects.

Depression

Shared sleep, concentration, guilt and anhedonia can inflate symptom correlations. Trials should separately report PTSD and depression outcomes. See the depression condition rather than treating depression as a PTSD subtype.

Substance use

Substances may function as avoidance/coping and also worsen sleep, arousal and adherence. Integrated and sequential approaches should be compared rather than assuming abstinence is always prerequisite (Coventry 2020, PMID 32813696), and the comparison has been made. A network meta-analysis of 24 randomized trials (from 39 systematically reviewed, 1995–2019) found integrated trauma-focused therapy for PTSD plus alcohol or other drug use disorder more effective at reducing PTSD symptoms at end of treatment than integrated non-trauma-focused therapy (SMD −0.30), AOD-focused psychotherapy (SMD −0.29) and other control psychotherapies (SMD −0.43), while alcohol-use severity responded to AOD medication versus placebo (SMD −0.36) (Hien 2024, PMID 37971855). A separate meta-analysis found modest benefits for trauma-focused intervention plus SUD intervention on PTSD post-treatment (SMD −0.36, 95% CI −0.64 to −0.08) and at 6–13 months (SMD −0.48, 95% CI −0.81 to −0.15) with a small alcohol-use benefit (SMD −0.23, 95% CI −0.44 to −0.02), no benefit for present-focused coping-skills approaches beyond SUD-only treatment, and a relatively high level of dropout across studies (Roberts 2022, PMID 35558682). The direction is consistent: withholding trauma-focused work until abstinence is achieved is not supported, but retention is the binding constraint.

Pain

Mutual maintenance models link avoidance, hypervigilance, catastrophising, sleep and disability. Existing childhood-trauma/CPTSD/pain evidence is sparse and largely observational (Karimov-Zwienenberg 2024, PMID 39213321).

TBI

PTSD and mild TBI share irritability, sleep, concentration and memory complaints; injury history and neurologic findings must be assessed independently. Symptom overlap prevents diagnosis by checklist alone.

GAD and other anxiety disorders

GAD is a neighbouring condition, not a PTSD subset. A meta-analysis pooling GAD, OCD, panic, social anxiety, ASD and PTSD reported overall CBT g=.56; that overall estimate is not a PTSD effect (Carpenter 2018, PMID 29451967).

Complex PTSD

CPTSD adds DSO symptoms under ICD-11 and is not shorthand for multiple comorbid diagnoses (Cloitre 2018, PMID 30178492) (Maercker 2022, PMID 35780794).

Sequencing

The right question is often whether concurrent, integrated or sequential care yields greater delivered benefit and retention. Exclusion-heavy efficacy trials answer this poorly.

Quantitative anchors

Measure Estimate Population/method Source
Complex-event component NMA systematic review + component NMA PTSD + comorbid mental health (Coventry 2020, PMID 32813696)
Childhood trauma/PTSD/CPTSD/pain 13 studies; 4 explicit linkage studies Chronic pain population (Karimov-Zwienenberg 2024, PMID 39213321)
Cross-disorder CBT review 41 studies; n=2,843 PTSD stratum only used here (Carpenter 2018, PMID 29451967)
PTSD + AOD network meta-analysis 24 RCTs from 39 reviewed studies (1995–2019) Integrated trauma-focused therapy vs alternatives (Hien 2024, PMID 37971855)
Integrated TF vs integrated non-TF SMD −0.30 for PTSD symptoms End of treatment (Hien 2024, PMID 37971855)
TF + SUD intervention, PTSD SMD −0.36 (95% CI −0.64 to −0.08) post-treatment Meta-analysis of psychological interventions (Roberts 2022, PMID 35558682)
TF + SUD intervention, PTSD at 6–13 months SMD −0.48 (95% CI −0.81 to −0.15) Same review (Roberts 2022, PMID 35558682)
TF + SUD intervention, alcohol use SMD −0.23 (95% CI −0.44 to −0.02) Same review (Roberts 2022, PMID 35558682)

Evidence ledger

The ledger lists the live-retrieved records used to bound this page. Inclusion does not make every record equally probative; design, population and comparator remain decisive.

PMID Year Evidence contribution Scope caution
32813696 2020 Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis. Synthesis: preserve included-population and certainty limits
39213321 2024 Childhood trauma, PTSD/CPTSD and chronic pain: A systematic review. Synthesis: preserve included-population and certainty limits
29451967 2018 Cognitive behavioral therapy for anxiety and related disorders: A meta-analysis of randomized placebo-controlled trials. Synthesis: preserve included-population and certainty limits
34893317 2022 Mental Health Consequences of Traumatic Brain Injury. PTSD-specific record; inspect design and population
30782414 2019 Traumatic brain injury. PTSD-specific record; inspect design and population
10795606 2000 Comorbidity of psychiatric disorders and posttraumatic stress disorder. PTSD-specific record; inspect design and population
38637955 2024 Posttraumatic stress disorder (PTSD) and complex PTSD in eating disorder treatment-seekers: Prevalence and associations with symptom severity. Comorbidity sample; do not infer a general PTSD estimate
32451021 2020 Telepsychiatry in Obstetrics. PTSD-specific record; inspect design and population
26237033 2015 Biofluid Biomarkers of Mild Traumatic Brain Injury: Whither Plasma Tau. PTSD-specific record; inspect design and population
21284062 2011 Mental disorders and traumatic injury. PTSD-specific record; inspect design and population
31191738 2019 Psychological Intervention in Traumatic Brain Injury Patients. PTSD-specific record; inspect design and population
38277308 2024 Comorbid treatment of traumatic brain injury and mental health disorders. PTSD-specific record; inspect design and population
21093682 2010 Neuropsychological assessment in traumatic brain injury. PTSD-specific record; inspect design and population
38892091 2024 Substance P's Impact on Chronic Pain and Psychiatric Conditions-A Narrative Review. Synthesis: preserve included-population and certainty limits
34952034 2022 Altered physical pain processing in different psychiatric conditions. PTSD-specific record; inspect design and population
33957654 2021 The Collision of Mental Health, Substance Use Disorder, and Suicide. PTSD-specific record; inspect design and population
38717128 2024 Stress Exposure and PTSD in a Cross-Sectional Residential Substance Use Treatment Sample. PTSD-specific record; inspect design and population
18801110 2008 Post-traumatic stress disorder in Canada. PTSD-specific record; inspect design and population
24978399 2014 Chronic pain and opioid use in US soldiers after combat deployment. PTSD-specific record; inspect design and population
21521385 2012 Post-traumatic stress disorder, depression and suicidality in inpatients with substance use disorders. PTSD-specific record; inspect design and population
19539412 2009 Post-traumatic stress disorder and suicidal behavior: A narrative review. Synthesis: preserve included-population and certainty limits
37303126 2023 Psychiatric comorbidities in older adults with posttraumatic stress disorder: A systematic review. Synthesis: preserve included-population and certainty limits
35125044 2022 Advanced brain age in deployment-related traumatic brain injury: A LIMBIC-CENC neuroimaging study. PTSD-specific record; inspect design and population
37240148 2023 Molecular Toxicology and Pathophysiology of Comorbid Alcohol Use Disorder and Post-Traumatic Stress Disorder Associated with Traumatic Brain Injury. PTSD-specific record; inspect design and population
25135781 2014 Bereavement: course, consequences, and care. PTSD-specific record; inspect design and population
30781888 2019 A Review of Epigenetics of PTSD in Comorbid Psychiatric Conditions. Synthesis: preserve included-population and certainty limits
30178492 2018 The International Trauma Questionnaire: development of a self-report measure of ICD-11 PTSD and complex PTSD. PTSD-specific record; inspect design and population
35780794 2022 Complex post-traumatic stress disorder. PTSD-specific record; inspect design and population
37971855 2024 Project harmony: A systematic review and network meta-analysis of psychotherapy and pharmacologic trials for comorbid posttraumatic stress, alcohol, and other drug use disorders. Network estimates across differing treatment targets
35558682 2022 A systematic review and meta-analysis of psychological interventions for comorbid post-traumatic stress disorder and substance use disorder. High dropout across included studies

Interpretation guardrails

  • Trauma exposure, post-traumatic symptoms, acute stress disorder, DSM-5 PTSD, ICD-11 PTSD and ICD-11 complex PTSD are not interchangeable populations.
  • A mixed-anxiety or transdiagnostic estimate is labelled as such; only a source’s PTSD stratum can be treated as a PTSD effect.
  • Comorbid depression is measured separately and cross-linked to the depression condition; it is not absorbed into PTSD.
  • Waitlist, treatment-as-usual, attention control and active treatment answer different causal questions.
  • Registration, statistical significance and diagnostic loss do not respectively prove completion, clinical importance or functional recovery.
  • This page synthesizes research and does not provide individual medical advice.

Minimum extraction frame for studies on this topic

Field What must be retained Why it changes interpretation
Diagnostic system DSM version, ICD version, full/subthreshold Case mix is not interchangeable
Diagnostic method Structured interview, clinician judgment, self-report cutoff Screening is not diagnosis
Index trauma Type, timing, repetition, direct/indirect/occupational Conditional risk and phenotype differ
Population Civilian, veteran, refugee, child/adolescent, mixed Transportability is empirical
Baseline severity Mean, SD, range and exclusion threshold Ceiling and floor effects alter change
CPTSD status ITQ/ICD-11 definition and DSO score Complexity cannot be inferred from trauma count
Comorbidity Depression, GAD, SUD, pain, TBI measured separately Shared symptoms can distort effects
Comparator Waitlist, usual care, attention, active treatment The estimand changes with comparator
Treatment dose Sessions offered/attended, duration, homework Assignment is not exposure
Outcome Symptoms, diagnosis, response, function, sleep Outcomes are not interchangeable
Time point End point and prespecified follow-up windows Acute benefit may not persist
Missing data Denominator, reasons, imputation and estimand Attrition can bias rank and magnitude
Adverse events Definitions, ascertainment and arm-level counts Absence of reporting is not absence of harm
Therapist/context Training, fidelity, allegiance, setting Delivery is part of the intervention
Funding/conflicts Sponsor role and analytic independence Especially material for proprietary packages

Claims this page does not make

  • It does not infer PTSD from trauma exposure alone.
  • It does not treat a self-report cutoff as equivalent to a structured diagnosis.
  • It does not convert a pooled anxiety-disorder effect into a PTSD effect.
  • It does not convert a depression outcome in a comorbid sample into a PTSD outcome.
  • It does not infer superiority from a statistically significant within-group change.
  • It does not infer equivalence from a non-significant between-group test.
  • It does not infer effectiveness from trial registration or mechanistic plausibility.
  • It does not assume military, civilian, refugee and pediatric estimates transport unchanged.
  • It does not average conflicting estimates that use different definitions.
  • It does not treat lack of adverse-event reporting as evidence of safety.

Evidence-updating triggers

Trigger Required response
New diagnostic revision Recalculate which populations prior estimates represent
New head-to-head RCT Compare against active treatment, not only waitlist
New individual-participant synthesis Revisit effect modifiers and transportability
Registry status change Verify results and linked publication before changing conclusions
Guideline update Separate evidence review from panel recommendation
Regulatory decision Record decision date and source; do not infer from efficacy papers
Safety signal Re-extract denominator, ascertainment and exposure time by arm
Contradictory replication Display estimates side by side; do not average definitions

Evidence updates should preserve the prior estimate and explain why the new study changes—or does not change—the inference.

Open questions

  • Which comorbidity combinations modify specific PTSD-treatment effects in within-trial analyses? (Coventry 2020, PMID 32813696)
  • Does integrated PTSD–SUD treatment improve both outcomes without increased dropout? (Coventry 2020, PMID 32813696)
  • Can pain and PTSD treatment target shared avoidance without conflating outcomes? (Karimov-Zwienenberg 2024, PMID 39213321)

References

  1. Coventry PA, et al. Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis. PLoS Med. 2020;17(8):e1003262. PMID 32813696
  2. Karimov-Zwienenberg M, et al. Childhood trauma, PTSD/CPTSD and chronic pain: A systematic review. PLoS One. 2024;19(8):e0309332. PMID 39213321
  3. Carpenter JK, et al. Cognitive behavioral therapy for anxiety and related disorders: A meta-analysis of randomized placebo-controlled trials. Depress Anxiety. 2018;35(6):502-514. PMID 29451967
  4. Howlett JR, et al. Mental Health Consequences of Traumatic Brain Injury. Biol Psychiatry. 2022;91(5):413-420. PMID 34893317
  5. Leikin JB Traumatic brain injury. Dis Mon. 2019;65(10):100857. PMID 30782414
  6. Brady KT, et al. Comorbidity of psychiatric disorders and posttraumatic stress disorder. J Clin Psychiatry. 2000;61 Suppl 7:22-32. PMID 10795606
  7. Day S, et al. Posttraumatic stress disorder (PTSD) and complex PTSD in eating disorder treatment-seekers: Prevalence and associations with symptom severity. J Trauma Stress. 2024;37(4):672-684. PMID 38637955
  8. Worley LLM, et al. Telepsychiatry in Obstetrics. Obstet Gynecol Clin North Am. 2020;47(2):333-340. PMID 32451021
  9. Peskind ER, et al. Biofluid Biomarkers of Mild Traumatic Brain Injury: Whither Plasma Tau. JAMA Neurol. 2015;72(10):1103-5. PMID 26237033
  10. Bryant RA Mental disorders and traumatic injury. Depress Anxiety. 2011;28(2):99-102. PMID 21284062
  11. Gómez-de-Regil L, et al. Psychological Intervention in Traumatic Brain Injury Patients. Behav Neurol. 2019;2019:6937832. PMID 31191738
  12. Ragsdale KA, et al. Comorbid treatment of traumatic brain injury and mental health disorders. NeuroRehabilitation. 2024;55(3):375-384. PMID 38277308
  13. Podell K, et al. Neuropsychological assessment in traumatic brain injury. Psychiatr Clin North Am. 2010;33(4):855-76. PMID 21093682
  14. Humes C, et al. Substance P's Impact on Chronic Pain and Psychiatric Conditions-A Narrative Review. Int J Mol Sci. 2024;25(11):5905. PMID 38892091
  15. Kim DJ, et al. Altered physical pain processing in different psychiatric conditions. Neurosci Biobehav Rev. 2022;133:104510. PMID 34952034
  16. Forray A, et al. The Collision of Mental Health, Substance Use Disorder, and Suicide. Obstet Gynecol. 2021;137(6):1083-1090. PMID 33957654
  17. Schacht RL, et al. Stress Exposure and PTSD in a Cross-Sectional Residential Substance Use Treatment Sample. Subst Use Addctn J. 2024;45(4):664-673. PMID 38717128
  18. Van Ameringen M, et al. Post-traumatic stress disorder in Canada. CNS Neurosci Ther. 2008;14(3):171-81. PMID 18801110
  19. Toblin RL, et al. Chronic pain and opioid use in US soldiers after combat deployment. JAMA Intern Med. 2014;174(8):1400-1. PMID 24978399
  20. Dore G, et al. Post-traumatic stress disorder, depression and suicidality in inpatients with substance use disorders. Drug Alcohol Rev. 2012;31(3):294-302. PMID 21521385
  21. Panagioti M, et al. Post-traumatic stress disorder and suicidal behavior: A narrative review. Clin Psychol Rev. 2009;29(6):471-82. PMID 19539412
  22. Baltjes F, et al. Psychiatric comorbidities in older adults with posttraumatic stress disorder: A systematic review. Int J Geriatr Psychiatry. 2023;38(6):e5947. PMID 37303126
  23. Dennis EL, et al. Advanced brain age in deployment-related traumatic brain injury: A LIMBIC-CENC neuroimaging study. Brain Inj. 2022;36(5):662-672. PMID 35125044
  24. Wang Z, et al. Molecular Toxicology and Pathophysiology of Comorbid Alcohol Use Disorder and Post-Traumatic Stress Disorder Associated with Traumatic Brain Injury. Int J Mol Sci. 2023;24(10):8805. PMID 37240148
  25. Zisook S, et al. Bereavement: course, consequences, and care. Curr Psychiatry Rep. 2014;16(10):482. PMID 25135781
  26. Blacker CJ, et al. A Review of Epigenetics of PTSD in Comorbid Psychiatric Conditions. Genes (Basel). 2019;10(2):140. PMID 30781888
  27. Cloitre M, et al. The International Trauma Questionnaire: development of a self-report measure of ICD-11 PTSD and complex PTSD. Acta Psychiatr Scand. 2018;138(6):536-546. PMID 30178492
  28. Maercker A, et al. Complex post-traumatic stress disorder. Lancet. 2022;400(10345):60-72. PMID 35780794
  29. Hien DA, et al. Project harmony: A systematic review and network meta-analysis of psychotherapy and pharmacologic trials for comorbid posttraumatic stress, alcohol, and other drug use disorders. Psychol Bull. 2024;150(3):319-353. PMID 37971855
  30. Roberts NP, et al. A systematic review and meta-analysis of psychological interventions for comorbid post-traumatic stress disorder and substance use disorder. Eur J Psychotraumatol. 2022;13(1):2041831. PMID 35558682